This study investigated if the use of blood pressure (BP)-interfering medication is common in patients hypertension. The study concluded that patients with new or treatment-resistant hypertension commonly take BP-interfering medication including non-steroidal anti-inflammatory drugs (NSAIDs).

This study investigated whether a systolic blood pressure (SBP) of 120 mm Hg or less is beneficial for patients with and without diabetes. This study concluded that this intensive blood pressure control improves cardiovascular outcomes.

This study evaluated the effect of angiotensin converting enzyme inhibitors (ACEIs) on the development of type 2 diabetes. 

This study evaluated the effect of the new direct renin inhibitor aliskiren (Tekturna), and compared its use in combination with different anti-hypertensive drugs.

This report includes new updates from the American College of Cardiology (ACC) and the American Heart Association (AHA) on the management of cardiovascular risk.

This study reviewed published data to formulate guidelines on monitoring blood pressure and the risk of cardiovascular disease.

They made a number of recommendations including lowering the threshold for stage 1 and stage 2 hypertension, the use of continuous blood pressure monitoring and pharmacological treatment strategies.

This study reviewed recent recommendations treating hypertension. 

This study investigated the effect of using ultrasound renal denervation to treat hypertension. They concluded that ultrasound renal denervation improved blood pressure control in patients with moderate hypertension.

This study investigated if there is an association between hypertension and dementia in patients aged 50 years and older. They found that elevated systolic blood pressure at age 50 is associated with an increased risk of dementia.